PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancerQiongshu Li(Beike Biotechnology (China)), Weibin Liu(Beike Biotechnology (China))Oncology LettersFebruary 16, 201810.3892/ol.2018.8075Cited by 25SaveCiteExport RISWatch citationsRelated PapersLow measles seropositivity rate among children and young adults: A sero-epidemiological study in southern China in 2008|Vaccine|2010|37